3091:HK:HK- (HKD)

ETF | Others |

Last Closing

USD 104.5

Change

+0.50 (+0.48)%

Market Cap

N/A

Volume

390.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.02 (+0.09%)

USD 159.33B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-0.04 (-0.05%)

USD 30.56B
2801:HK iShares Core MSCI China ETF

+0.08 (+0.34%)

USD 22.44B
2823:HK iShares FTSE A50 China

N/A

USD 17.65B
83188:HK ChinaAMC CSI 300 Index ETF

N/A

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.01 (+0.97%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.08 (+0.71%)

USD 9.22B
82822:HK CSOP FTSE China A50

-0.02 (-0.17%)

USD 8.59B
9010:HK iShares Core MSCI AC Asia ex J..

-0.19 (-2.58%)

USD 3.03B

ETFs Containing 3091:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.05% 52% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.05% 51% F 50% F
Trailing 12 Months  
Capital Gain 15.91% 68% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.91% 67% D+ 63% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.19% 64% D 58% F
Dividend Return 1.19% 61% D- 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.50% 53% F 76% C+
Risk Adjusted Return 6.13% 62% D 56% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike